Six months on GLP-1: separating the real results from the hype

What did @alexismpotter actually say?

Here is the honest answer: nothing medically relevant. The transcript attributed to this video is not a coherent health claim. The words, "I'm putting up points on the board in the shake of the deal" and "your penis" are not GLP-1 commentary. They appear to be lyrics, a joke, or a badly garbled audio capture, not a first-person account of semaglutide use.

The caption tells a different story. The written framing describes six months on a GLP-1 medication, emotional transformation, and a history of failed weight loss attempts. That narrative is common, relatable, and worth examining on its own terms. But the spoken words in this video do not match that framing at all. Any fact-check of the audio itself would be fact-checking nonsense syllables, so we are working from the caption context and the broader claims implied by the video's framing and hashtags.

Does the science back up the caption's implied claims?

The core implication, that GLP-1 receptor agonists can produce meaningful, sustained weight loss after other interventions have failed, is well supported. This is not influencer wishful thinking. It is one of the more robustly replicated findings in obesity pharmacology right now.

The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed participants on semaglutide 2.4mg lost an average of 14.9% of body weight over 68 weeks versus 2.4% on placebo. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide produced up to 22.5% mean weight reduction at the highest dose. These are not trivial numbers. For people who have cycled through diets, exercise programs, and behavioral interventions without lasting results, GLP-1 and dual GIP/GLP-1 agonists represent a genuinely different mechanism, appetite regulation at the hypothalamic level, not just caloric restriction willpower.

The emotional framing, "reclaiming my life" and "learning to love myself," is harder to quantify but not without basis. Quality-of-life measures in STEP trials showed improvements in physical functioning and self-reported wellbeing alongside weight reduction.

What did they get wrong, or right?

The caption gets the emotional arc right. People who have struggled with weight for years and experienced repeated failure are not weak or undisciplined. The biology of obesity involves leptin resistance, altered satiety signaling, and metabolic adaptation that makes keeping weight off after caloric restriction genuinely difficult. GLP-1 medications work on some of those mechanisms directly.

What the video gets wrong by omission is significant, though. There is no mention of the fact that weight typically returns when people stop the medication. Rubino et al. (2021, Diabetes, Obesity and Metabolism) found that one year after discontinuing semaglutide, participants regained about two-thirds of their lost weight. That is not a reason to avoid GLP-1 therapy, but it is information anyone six months in deserves to have.

The hashtag framing, particularly "healthtransformation" and "takingmylifeback," implies a permanent change. The current evidence suggests these medications are likely long-term or indefinite treatments for most people, not a six-month reset. That distinction matters for anyone watching and making decisions.

What should you actually know?

GLP-1 receptor agonists are not a shortcut, and they are not a cure. They are an effective pharmacological tool with a real evidence base and real side effects. Nausea, vomiting, and gastrointestinal discomfort are common, especially during dose escalation. Rare but serious risks include pancreatitis and, in rodent studies, thyroid C-cell tumors, which is why these medications carry a black box warning for people with a personal or family history of medullary thyroid carcinoma or MEN2.

Compounded versions of semaglutide and tirzepatide have been widely available during shortage periods, but compounded drugs are not FDA-approved and are not equivalent to brand-name formulations in terms of verified potency, purity, or sterility standards. Anyone considering a compounded peptide should understand that distinction clearly before starting.

If you are six months in and feeling good, that is genuinely worth acknowledging. But talk to your prescriber about long-term plans, not TikTok comment sections.